STOCK TITAN

Tandem Diabetes Care to Participate in the 33rd Annual Piper Sandler Virtual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Tandem Diabetes Care (NASDAQ: TNDM) will participate in the 33rd Annual Piper Sandler Virtual Healthcare Conference on December 2, 2021. A pre-recorded fireside chat featuring CEO John Sheridan and CFO Leigh Vosseller will be available starting November 22, 2021, at 10:00 AM ET. Investors can access the chat on the Tandem Diabetes Investor Center website under 'Events & Presentations.'

Tandem Diabetes is committed to enhancing diabetes management through innovative solutions, highlighted by its flagship t:slim X2™ insulin pump.

Positive
  • None.
Negative
  • None.

SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, is scheduled to participate in the 33rd Annual Piper Sandler Virtual Healthcare Conference on December 2, 2021.

In advance of the virtual conference, a pre-recorded fireside chat with John Sheridan, President and Chief Executive Officer, and Leigh Vosseller, Executive Vice President and Chief Financial Officer, will be made available on Monday, November 22 at 10:00am Eastern Time (7:00am Pacific Time). Interested parties may access the fireside chat by visiting the Tandem Diabetes Care Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section.

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. The Company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. Tandem’s flagship product, the t:slim X2™ insulin pump, is capable of remote software updates using a personal computer and features integrated continuous glucose monitoring. Tandem is based in San Diego, California.

Tandem Diabetes Care is a registered trademark and t:slim X2 is a trademark of Tandem Diabetes Care, Inc.

Follow Tandem Diabetes Care on Twitter @tandemdiabetes; use #tslimX2, and $TNDM.
Follow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes.
Follow Tandem Diabetes Care on LinkedIn at https://www.linkedin.com/company/tandemdiabetes.

Media Contact:

Steve Sabicer

714-907-6264

ssabicer@thesabicergroup.com

Investor Contact:

Susan Morrison

858-366-6900

IR@tandemdiabetes.com

Source: Tandem Diabetes Care, Inc.

FAQ

When will Tandem Diabetes Care participate in the Piper Sandler Virtual Healthcare Conference?

Tandem Diabetes Care will participate in the 33rd Annual Piper Sandler Virtual Healthcare Conference on December 2, 2021.

What time will the fireside chat with Tandem's CEO and CFO be available?

The pre-recorded fireside chat with Tandem's CEO John Sheridan and CFO Leigh Vosseller will be available on November 22, 2021, at 10:00 AM ET.

Where can I access the fireside chat of Tandem Diabetes Care?

The fireside chat can be accessed on the Tandem Diabetes Care Investor Center website in the 'Events & Presentations' section.

What is Tandem Diabetes Care known for?

Tandem Diabetes Care is known for innovative diabetes technology, especially the t:slim X2 insulin pump, which allows remote software updates and integrates continuous glucose monitoring.

Tandem Diabetes Care, Inc.

NASDAQ:TNDM

TNDM Rankings

TNDM Latest News

TNDM Stock Data

1.85B
65.68M
0.75%
115.2%
13.89%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
San Diego